BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8391870)

  • 61. Indications for the presence of an atypical protease-activated receptor on rat platelets.
    Ruef J; Kacharava A; Pohl J; Bode C; Runge MS
    Ann Hematol; 2000 Nov; 79(11):604-11. PubMed ID: 11131919
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Activation of vascular thrombin receptors mediates cardiac response to alpha-thrombin in isolated, perfused guinea pig heart.
    Damiano BP; Mitchell JA; Cheung WM; Falotico R
    Am J Physiol; 1996 May; 270(5 Pt 2):H1585-96. PubMed ID: 8928863
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Platelet interaction with polymerizing fibrin.
    Niewiarowski S; Regoeczi E; Stewart GJ; Senyl AF; Mustard JF
    J Clin Invest; 1972 Mar; 51(3):685-99. PubMed ID: 4622107
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Factors influencing the deaggregation of human and rabbit platelets.
    Kinlough-Rathbone RL; Mustard JF; Perry DW; Dejana E; Cazenave JP; Packham MA; Harfenist EJ
    Thromb Haemost; 1983 Jun; 49(3):162-7. PubMed ID: 6308846
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fibrinogen-independent aggregation and deaggregation of human platelets: studies in two afibrinogenemic patients.
    Cattaneo M; Kinlough-Rathbone RL; Lecchi A; Bevilacqua C; Packham MA; Mustard JF
    Blood; 1987 Jul; 70(1):221-6. PubMed ID: 3109523
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ADP-dependence of platelet activation induced by a thrombin receptor agonist.
    Savi P; Dol F; Herbert JM
    Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):115-9. PubMed ID: 8392699
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Coordinate activation of human platelet protease-activated receptor-1 and -4 in response to subnanomolar alpha-thrombin.
    Ofosu FA; Dewar L; Craven SJ; Song Y; Cedrone A; Freedman J; Fenton JW
    J Biol Chem; 2008 Oct; 283(40):26886-93. PubMed ID: 18682394
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunologic analysis of the cloned platelet thrombin receptor activation mechanism: evidence supporting receptor cleavage, release of the N-terminal peptide, and insertion of the tethered ligand into a protected environment.
    Norton KJ; Scarborough RM; Kutok JL; Escobedo MA; Nannizzi L; Coller BS
    Blood; 1993 Oct; 82(7):2125-36. PubMed ID: 8400262
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aggregation-related association of lipid with the cytoskeleton of rabbit and human platelets prelabeled with [3H]palmitic acid. Similar effects of adenosine diphosphate- and thrombin-induced aggregation.
    Livne A; Packham MA; Guccione MA; Mustard JF
    J Clin Invest; 1988 Feb; 81(2):288-99. PubMed ID: 2828426
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
    Grossklaus C; Damerau B; Lemgo E; Vogt W
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):71-6. PubMed ID: 1004644
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of sodium periodate on platelet functions.
    Cazenave JP; Reimers HJ; Kinlough-Rathbone RL; Packham MA; Mustard JF
    Lab Invest; 1976 May; 34(5):471-81. PubMed ID: 178961
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of amino sugars on platelet aggregation and on fibrinogen binding.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Haemost; 1984 Aug; 52(1):75-80. PubMed ID: 6495268
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aggregation of human platelets in plasma by porcine blood cells in vitro is probably mediated by thrombin generation.
    Benatuil L; Fernandez AZ; Romano E
    Xenotransplantation; 2003 Sep; 10(5):454-9. PubMed ID: 12950988
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
    Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
    Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Loss of sulfated proteoglycan from the surface of rabbit platelets during adenosine 5'-diphosphate-induced aggregation.
    Ward JV; Radojewski-Hutt AM; Packham MA; Haslam RJ; Mustard JF
    Lab Invest; 1976 Oct; 35(4):337-42. PubMed ID: 979164
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity.
    Jennings LK; White MM; Mandrell TD
    Thromb Haemost; 1995 Dec; 74(6):1551-6. PubMed ID: 8772236
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Actions of thrombin and thrombin receptor peptide analogues in gastric and aortic smooth muscle: development of bioassays for structure-activity studies.
    Yang SG; Laniyonu A; Saifeddine M; Moore GJ; Hollenberg MD
    Life Sci; 1992; 51(17):1325-32. PubMed ID: 1328791
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparative study of platelet dense granule constituents.
    Meyers KM; Holmsen H; Seachord CL
    Am J Physiol; 1982 Sep; 243(3):R454-61. PubMed ID: 7114301
    [TBL] [Abstract][Full Text] [Related]  

  • 80. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.